Brief: Zhaoke Ophthalmology Ltd Says HY Revenue Rmb11.3 Mln
Aug 23 (Reuters) - Zhaoke Ophthalmology Ltd 6622.HK :
* HY REVENUE RMB11.3 MILLION
* HY LOSS FOR PERIOD RMB233.8 MILLION VERSUS LOSS RMB161.0
MILLION
* EXPECT TO RECEIVE APPROVAL FOR COMMERCIALIZATION OF CSA
OPHTHALMIC GEL FROM NMPA IN 2024
* ACTIVELY PREPARING FOR CHINA IND APPLICATION FOR BRIMOCHOL
PF IN
SECOND HALF OF YEAR AND TO START PHASE I IN 2024
Source text for Eikon: ID:nHKSWsY8G
Further company coverage: 6622.HK
(Reporting by Adwitiya Srivastava)
((Adwitiya.Srivastava@thomsonreuters.com;))
Recent news on Zhaoke Ophthalmology
See all newsBrief: Zhaoke Ophthalmology Says Its Facility In Guangzhou Obtains GMP Certification From Australia's TGA
China's Zhaoke Ophthalmology H1 revenue rises
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved By Macau Pharmaceutical Administration Bureau
Brief: Zhaoke Ophthalmology Enters Into Definitive Agreement For Acquisition Of Global Rights To NVK002
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved For Use At Boao Super Hospital